14th Meeting of EUNOS, Porto, Portugal

GenSight will participate to the 14th Meeting of the European Neuro-ophthalmology Society (EUNOS) in Porto, Portugal from June 16-19, 2019.

96-week data from the REVERSE Phase III trial of GS010 will be presented by by Dr. Valerio Carelli, MD, PhD, Associate Professor, Chief of the Laboratory of Neurogenetics, Department of Biomedical and NeuroMotor Sciences, University of Bologna School of Medicine, Italy. Dr. Carelli is a Principal Investigator of the REVERSE trial.

“rAAV2/2-ND4 Treatment of Leber Hereditary Optic Neuropathy: 96-Week Data from the REVERSE Phase III Clinical Trial” presented by Valerio Carelli, MD, PhD, Associate Professor, Department of Biomedical and NeuroMotor Sciences, University of Bologna School of Medicine, Italy

• Free Papers Session
• Wednesday, June 19, 9:36 am – 9:47 am WEST